APA (7th ed.) Citation

Almutair, A., Almutair, A., Almutair, A., Almulhem, B., Almulhem, B., & Almulhem, B. (2024). Semaglutide as a potential therapeutic alternative for HNF1B-MODY: A case study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Almutair, Angham, Angham Almutair, Angham Almutair, Beshaier Almulhem, Beshaier Almulhem, and Beshaier Almulhem. Semaglutide as a Potential Therapeutic Alternative for HNF1B-MODY: A Case Study. Frontiers Media S.A, 2024.

MLA (9th ed.) Citation

Almutair, Angham, et al. Semaglutide as a Potential Therapeutic Alternative for HNF1B-MODY: A Case Study. Frontiers Media S.A, 2024.